89
Views
10
CrossRef citations to date
0
Altmetric
Case Report

Ephedrine‐Induced Cardiac Ischemia: Exposure Confirmed with a Serum Level

, M.D., , M.D., , M.D. & , M.D.
Pages 849-853 | Published online: 30 Oct 2003

References

  • Haller C. A., Benowitz N. L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Eng J Med 2000; 343(25)1833–1838
  • Samenuk D., Link M. S., Homoud M. K., Contreras R., Theohardes T. C., Wang P. J., Mark Estes N. A., III. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002; 77: 12–16
  • Traub S. J., Hoyek W., Hoffman R. S. Dietary supplements containing ephedra alkaloids. N Engl J Med 2001; 344(14)1096
  • Cockings J. G.L., Brown M. A. Ephedrine abuse causing acute myocardial infarction. Med J Aust 1997; 167(4)199–200
  • Perrone J. Dieting agents and regimens. Goldfrank's Toxicologic Emergencies7th ed., L. R. Goldfrank, N. E. Flomenbaum, N. A. Lewin, M. A. Howland, R. S. Hoffman, L. S. Nelson. McGraw‐Hill, New York 2002; 571–577
  • Johnson D. A., Hricik J. G. The pharmacology of alpha‐adrenergic decongestants. Pharmacotherapy 1993; 13: 110S–115S
  • Haller C. A., Jacob P., III, Benowitz N. L. Pharmacology of ephedra alkaloids and caffeine after single‐dose dietary supplement use. Clin Pharmacol Ther 2002; 71(6)421–432
  • Gurley B. J., Gardner S. F., White L. M., Wang P. L. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang). Ther Drug Monit 1998; 20(4)439–445
  • Berlin I., Warot D., Aymard G., Acquaviva E., Legrand M., Labarthe B., Peyron I., Diquet B., Lechat P. Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects. Eur J Clin Pharmacol 2001; 57: 447–455
  • White L. M., Gardner S. F., Gurley B. J., Marx M. A., Wang P. L., Estes M. Pharmacokinetics and cardiovascular effects of ma‐huang (Ephedra sinica) in normotensive adults. J Clin Pharm 1997; 37: 116–122
  • Pickup M. E., May C. S., Ssendagire R., Paterson J. W. The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatment. Br J Clin Pharmacol 1976; 3: 123–134
  • Gurley B. J., Wang P., Gardner S. F. Ephedrine‐type alkaloid content of nutritional supplements containing Ephedra sinica (ma‐huang) as determined by high performance liquid chromatography. J Pharm Sci 1998; 87: 1547–1553
  • Gurley B. J., Gardner S. F., Hubbard M. A. Content versus label claims in ephedra‐containing dietary supplements. Am J Health Syst Pharm 2000; 57: 963–969

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.